Article · 16 Oct 2024
Byline
K. Blum
Articles whose byline reads K. Blum, printed as Kenneth Blum and Blum K. Different authors can share a byline.
- Articles
- 56
- Latest year
- 2024
Articles
Newest first. Showing 1–25 of 56 articles.
Perspective · 29 Jun 2023
Evidence for the Drd2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)
Conference abstract · 16 Feb 2023
Evidence based clinical analytics supporting the Genetic Addiction Risk Severity (gars) assessment to early identify probands in Addiction psychiatry
Commentary · 30 May 2022
A Brief Comment on Tandem Repeat's Insights
Conference abstract · 15 May 2022
Functional interplay between central and autonomic nervous systems
Other · 5 May 2021
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS) ; Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms
Research article · 30 Nov 2020
Introducing Precision Addiction Management (PAM) utilizing polymorphic matched algorithms and Pro-Dopamine regulation to combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) globally
Conference abstract · 28 Oct 2020
Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors
Conference abstract · 28 Jan 2020
Introducing and#8220;Precision Addiction Management (PAMandreg;)and#8221; utilizing polymorphic matched alogarithms and Pro-Dopamine regulation to combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) globally
Conference abstract · 2019
Genetic Addiction Risk Score (GARS®) with precision Pro-Dopamine Regulation matched to polymorphic risk alleles to combat Reward Deficiency Syndrome (RDS) including Substance Use Disorder (SUD) globally
Conference abstract · 2018
Introducing precision addiction management of Reward Deficiency Syndrome, the construct that underpins all addictive behaviors
Conference abstract · 2018
Treating Reward Deficiency Syndrome (RDS) with a nutrigenomic dopaminergic brain activator by targeting reward gene polymorphisms utilizing genetic algorithms
Conference abstract · 27 Aug 2014
Genetic addiction risk score (GARSrx), comprehensive analysis of reported drugs (CARD) dopamine agonist therapy (kb220z): Embracing genetic prediction of addiction risk severity for pain and addiction treatment
Conference abstract · 27 Aug 2014
3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces resting state functional connectivity in rat brain
Commentary · 5 Jul 2014
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?
Letter · 30 Apr 2014
Genome Wide Sequencing Compared to Candidate Gene Association Studies for Predisposition to Substance Abuse a Subset of Reward Deficiency Syndrome (RDS): Are we throwing the Baby Out with the Bathwater?
Research article · 26 Apr 2014
Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Patterns
Case report · 20 Feb 2014
Quantitative Electroencephalography Analysis (qEEG) of Neuro-Electro- Adaptive Therapy 12™ [NEAT12] Up-Regulates Cortical Potentials in an Alcoholic during Protracted Abstinence: Putative Anti-Craving Implications
Book review · 10 Feb 2014
Everything you Need to Know about Global Alcohol Policy
Editorial · 18 Jan 2014
Reward Deficiency Solution System (RDSS)
Research article · 2014
Hypothesizing that Putative Dopaminergic, Melatonin, Benzodiazepine Reward Circuitry Receptor(s) Activator Provides Sleep Induction Benefits
Editorial · 2014
Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS)
Letter · 2014
Raising Endogenous Brain Levels of Kynurenic Acid May Produce Anti-Reward and Enhance Suicide Ideation
Short communication · 2014
Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?
Short communication · 2014

